Marsh McLennan (MRSH)
Financials · Insurance brokers and professional services · NYSE
Global professional services firm delivering risk consulting, insurance brokerage, and related advisory services to corporate and individual clients across industries.
What Marsh McLennan does
Marsh & McLennan is a global professional services company that provides consulting, insurance brokerage, and risk management solutions. The company operates through two main segments: Marsh & McLennan Agency (MMA), which offers insurance brokerage, employee benefits consulting, and risk services; and Mercer, which provides human capital and investment consulting services. The company serves multinational corporations, mid-size companies, and individuals across diverse industries, with operations spanning North America, Europe, and other regions.
Themes: Risk management, Insurance brokerage, Employee benefits, Human capital consulting, Investment advisory
Fundamentals
- Price$192.01 as of 2026-08-21 close
- Market cap$91.6B as of 2026-08-21
- 1-year return-9.0% 2025-08-21 close $211.11 → 2026-08-21 close $192.01
- P/E22.47 as of 2026-08-24
- Net margin+14.2% as of 2026-08-24
- ROE+26.5% as of 2026-08-24
- Debt / equity1.35 as of 2026-08-24
- Revenue growth (YoY)+8.3% as of 2026-08-24
- Revenue CAGR (3y)+9.2% SEC XBRL
- Beta0.58 as of 2026-08-24
- Last reported earnings2026-07-21 SEC EDGAR Form 8-K (Item 2.02)
Dividend: yield +2.0%; at least 4 years of non-decreasing per-share dividends (SEC XBRL) — we do not hold the year before it, so the real streak may be longer.
How MRSH compares in its sector
- price-to-earnings ratiotop 25% 525 covered Financials peers, as of 2026-08-24
- net profit marginmiddle range 538 covered Financials peers, as of 2026-08-24
- operating marginmiddle range 534 covered Financials peers, as of 2026-08-24
- return on equitytop 10% 575 covered Financials peers, as of 2026-08-24
- 3-year revenue CAGRmiddle range 347 covered Financials peers
- indicated dividend yieldmiddle range 453 covered Financials peers, as of 2026-08-24
- free cash flow (absolute dollars, latest fiscal year)top 10% 431 covered Financials peers, as of FY2025
Position among covered Financials companies that report each metric (minimum 5 peers). A relative position within our covered catalog — not a valuation, quality, or investment judgment. A higher percentile is simply a higher value (for P/E, more expensive on earnings — never "better"). Informational only.
Top 10 scores & list membership
MRSH is not currently in any published Top 10 list. Its scores are below.
Long-term score
47.2 #607 of 987 scored · #170 of 191 in Financials
Profitability 71st (return on equity 26.5%, operating margin 21.6%) and growth 62nd (3-year revenue CAGR 9.2%, revenue growth year over year 8.3%); weakest is valuation (17th, price to earnings 23.5 (within its sector)).
Short-term score
68.2 #16 of 1,704 scored · #3 of 277 in Financials
Catalysts 82nd: open-market insider buys in 90 days 24, analysts have raised their average price target by 0.5% since the prior reading; setup 78th: no fresh 20-day breakout up or down; weakest is momentum 48th: near the top of its 14-day range (overbought).
Scores as of 21 Aug 2026. Each bar is a percentile: how this company ranked against every company the score ranked, 0–100. A list is a published formula and its output, not a recommendation. Method version 2.
Dividend coverage (FY2025)
Covered by reported results. In FY2025, MRSH's dividend was covered by reported results (earnings payout 41%, free-cash-flow payout 34%). This describes past coverage, not a forecast.
- Earnings payout41% dividends / net income
- Free-cash-flow payout34% dividends / (operating cash flow − capex)
Coverage derived from reported SEC EDGAR XBRL figures for FY2025 (dividends paid vs. net income and free cash flow, same fiscal year). This describes PAST coverage for one fiscal year — it does not predict whether a dividend will be maintained, raised, or cut, and a one-year payout ratio can be distorted by non-recurring items. Informational only — not financial advice.
How Marsh McLennan looks technically
Marsh McLennan (MRSH) is trading 8.2% above its 200-day average, the long-term trend line — a longer-term uptrend. Its 50-day average crossed above its 200-day average about 5 trading days ago — a "golden cross", a bullish long-term signal. A strong uptrend is in place — ADX, a 0–100 trend-strength gauge, is 33, with buyers in control. Momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 60, neither overbought (above 70) nor oversold (below 30). MACD, a trend-momentum gauge, turned bearish about 10 trading days ago (its momentum flipped negative). It made a new 20-day high about 18 trading days ago.
Trend
9
| Distance from the 200-day | it is trading 8.2% above its 200-day average, the long-term trend line — a longer-term uptrend | +8.2% |
|---|---|---|
| 50-day moving average | its average price over the last 50 trading days — a short-term trend line — is $179.57 | $179.57 |
| 200-day moving average | its average price over the last 200 trading days — the long-term trend line — is $177.43 | $177.43 |
| Swing structure | each recent peak has been higher than the one before it and each dip has been shallower — the pattern chart-watchers call an uptrend, which describes where price has already been and not where it goes next | higher highs and higher lows |
| Last swing turn | its last significant turn was a swing high 23 calendar days ago — the swings before that are what the structure reading is measured on | 23 sessions |
| Wave structure | its recent swings can be read as a five-part upward sequence — what Elliott-wave chartists call an impulse — now in the fourth leg, a pullback against that upward direction; the labelling fails if price closes below 170.15. It is one of several labellings that fit, and it describes the swings already printed, not what comes next. The same swings also read as a completed three-part correction. | possible upward five-wave sequence, in wave 4 (one of several readings) |
| Since the 50/200 cross | its 50-day average crossed above its 200-day average about 5 trading days ago — a "golden cross", a bullish long-term signal | 5 sessions |
| Above the 200-day after a dip | it recently dipped to its 200-day average (the long-term trend line) and has since climbed back above it — now about 8.2% above | +8.2% |
| Trend strength (14-day ADX) | a strong uptrend is in place — ADX, a 0–100 trend-strength gauge, is 33, with buyers in control | 32.8 |
Momentum
3
| 14-day RSI | momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 60, neither overbought (above 70) nor oversold (below 30) | 59.7 |
|---|---|---|
| Position in its 14-day range | it is trading near the top of its 14-day range ($184.13 to $193.73) — its "stochastic" reading is 82 out of 100, where 0 would mean closing exactly at the 14-session low and 100 exactly at the high. This measures WHERE the price sits inside its recent range, which is a different question from the RSI beside it: RSI is a momentum gauge, measuring how FAST the price has been moving, so a stock can drift quietly to the bottom of its range with an ordinary RSI, or fall sharply and still sit in the middle. It has been climbing within that range over the last few sessions. | 82.1 |
| Since the MACD crossed zero | MACD, a trend-momentum gauge, turned bearish about 10 trading days ago (its momentum flipped negative) | 10 sessions |
Range
12
| 52-week high | its highest closing price over the past year (about 252 trading days) was $213.80 | $213.80 |
|---|---|---|
| From the 52-week high | it is 10.2% below its 52-week high (its highest price of the past year) | -10.2% |
| Above the 52-week low | it is 22.6% above its 52-week low (its lowest price of the past year) | +22.6% |
| Below the 52-week high | it is 10.2% below its highest point of the past year | 10.2% |
| Since a 20-day breakout | it made a new 20-day high about 18 trading days ago | 18 sessions |
| Since a 55-day breakout | it made a new 55-day high about 18 trading days ago | 18 sessions |
| All-time high | its highest closing price on record is $248.00 (set on 2025-04-04) | $248.00 |
| Given back of the 52-week move | over the past year its closes ranged ($157.32 to $211.21), and it has recovered close to two thirds of its fall from last year’s high — 64% of it. Chart-watchers call 61.8%-65% given back the "golden pocket", and this is inside it — for this company that is $190.62 to $192.35. It is watched widely enough that orders cluster there, which is the honest reason it matters; it is not a forecast. | 64.4% |
| From the all-time high | it is 22.6% below its all-time high | -22.6% |
| Nearest price level | it is trading 1.5% below a resistance level at $194.87 — a price it turned at three times since 2025-08-01, most recently on 2026-02-04. Since 2024-08-21 it has 7 such levels below the current price and 8 above. Levels like these describe where the price has reversed or paused before; they are not a forecast of where it will go. | +1.5% |
| All-time low | its lowest closing price on record is $2.29 (set on 1980-12-08) | $2.29 |
| Above the all-time low | it is 8278.6% above its all-time low | +8,279% |
Volatility
5
| Band width vs its own 6 months | day-to-day price swings are narrower than usual versus its own recent 6-month history (tighter than about 84% of it) | 16th percentile |
|---|---|---|
| Typical daily range | in a typical session it travels about $4.34 between its high and its low — about 2.3% of its price. That is its "average true range" over the last 14 sessions, which also counts the distance from the previous close, so a day that opens well away from yesterday counts as the large move it was | $4.34 |
| Bollinger bands (20-day, ±2σ) | most of its recent trading has stayed between about $183.96 and $196.48 — the "Bollinger bands", a range drawn two standard deviations either side of its 20-day average price, which widens when the stock gets more volatile and narrows when it settles | $183.96 – $190.22 – $196.48 |
| Typical daily range (% of price) | its price moves about 2.3% in a typical session — calmer than most companies we cover. This is the average gap between a session's high and low over the last 14 sessions, counting overnight moves, expressed against the current price so it can be compared with companies trading at any price | 2.3% |
| Stretch from the 200-day average | it is trading 3.4 daily ranges above its 200-day average price (8.2% above it in plain percentage terms) — a way of asking how far it has stretched from its own average in units of how far it normally moves in a day, so a calm company and a jumpy one can be compared on the same scale | 3.4 daily ranges above its 200-day average |
Volume
1
| Volume vs its 30-day average | trading volume is about normal versus its 30-day average | 1.08× |
|---|
Analyst
2
| Change in the average price target | analysts have raised their average price target by 0.5% since the prior reading | +0.5% |
|---|---|---|
| Change in the consensus rating | not available for this company yet | n/a |
Candlestick patterns
2
| Since a doji | 9 sessions ago it opened and closed at almost the same price after trading through a wider range — a "doji", the classic picture of buyers and sellers finishing the session level | 9 sessions ago |
|---|---|---|
| Since a bullish engulfing | 8 sessions ago it opened below the previous session's close and finished above that session's open — a "bullish engulfing" pair, where one up day more than undid the down day before it | 8 sessions ago |
Price gaps
3
| Gap at the open | it opened on 2026-08-21 0.4% above the previous session's close — an overnight gap, the part of the move that happened while the market was shut, and traded back through that level before the close | +0.4% |
|---|---|---|
| Open gap | it gapped 2.8% above the previous close 19 sessions ago and has not traded back through the level it left behind at 176.4 — an "unfilled gap", which describes a price range no trade has since crossed and is not a forecast that it will be crossed | +2.8% |
| Gap filled | a 2.5% gap up opened on 2026-07-21 has been "filled" 22 sessions ago — price traded back through the level the gap left behind, and it closed again during the very session that opened it | 22 sessions ago |
Price streaks
1
| Closing streak | it has closed higher 4 sessions in a row, a +4.23% move over the run — an unbroken run of up days, which describes what has already happened and says nothing about the next session | 4 sessions up |
|---|
Relative strength
4
| vs market, 1 month | over the past 1 month this stock beat the market by 3.4 percentage points (the stock gained 5.7% while the market gained 2.3%) | +3.4% |
|---|---|---|
| vs market, 3 months | over the past 3 months this stock beat the market by 13.2 percentage points (the stock gained 16.3% while the market gained 3.1%) | +13.2% |
| vs market, 6 months | over the past 6 months this stock lagged the market by 4.0 percentage points (the stock gained 7.1% while the market gained 11.1%) | -4.0% |
| vs market, 12 months | over the past 12 months this stock lagged the market by 29.5 percentage points (the stock lost 9.0% while the market gained 20.5%) | -29.5% |
Signal agreement
2
| Bullish technical signals | 4 of the 9 technical signals we can compute for it are currently in a bullish state: a strong uptrend, with buyers in control, a "golden cross" — its 50-day average is above its 200-day, trading above its 200-day average, trading above the Ichimoku cloud — these describe past price behaviour, not a forecast | 4 of 9 |
|---|---|---|
| Bearish technical signals | 3 of the 9 technical signals we can compute for it are currently in a bearish state: MACD momentum is negative, lagging the market over 6 months, near the top of its 14-day range (overbought) — these describe past price behaviour, not a forecast | 3 of 9 |
Trend (Ichimoku cloud)
1
| Vs the Ichimoku cloud | trading 10% above the Ichimoku cloud — a band drawn from where its own highs and lows sat up to 2026-07-15 and projected forward over today's price, the side traders read as an established uptrend, with the band below acting as the level that would have to give way. The band itself is moderate, spanning 2.4% of the share price. | +10.3% |
|---|
Volume-weighted price
2
| Vs this year’s average price paid | the price is 9% above the average price paid so far this year, so the typical buyer over that stretch is showing a gain. That average is $175.69 — a volume-weighted average of daily closes over 159 sessions, not a true tick-by-tick VWAP. | +9.3% |
|---|---|---|
| Vs the average paid since it last reported | the price is 2% above the average price paid since it last reported on 2026-07-21 (its 10-Q), so the typical buyer over that stretch is showing a gain. That average is $189.01 — a volume-weighted average of daily closes over 23 sessions, not a true tick-by-tick VWAP. | +1.6% |
Price levels it has turned at before
MRSH last closed at $192.01 on 2026-08-21. Since 2024-08-21 it has turned at 7 prices below its last close and 8 above; the 3 nearest below and the 3 nearest above are listed, nearest first.
| Level | Side | Distance | Evidence |
|---|---|---|---|
| $194.87 | Resistance | 1.5% above the last close | turned there three times · 2025-08-01 to 2026-02-04 |
| $188.34 | Support | 1.9% below the last close | turned there three times · 2025-12-16 to 2026-02-27 |
| $184.79 | Support | 3.8% below the last close | turned there four times · 2025-10-16 to 2026-04-16 |
| $179.59 | Support | 6.5% below the last close | turned there three times · 2025-12-08 to 2026-03-23 |
| $208.96 | Resistance | 8.8% above the last close | turned there five times · 2024-12-19 to 2025-10-10 |
| $215.51 | Resistance | 12.2% above the last close | turned there 7 times · 2024-11-01 to 2025-08-20 |
A level is a price this company reversed or paused at more than once — they describe past behaviour, not a forecast of where the price will go.
Wave structure
Its recent swings can be read as a five-part upward sequence — what Elliott-wave chartists call an impulse — now in leg 4 of five, a pullback against that direction.
This labelling fails — stops being a possible reading at all — if it closes below $170.15.
This is one of several labellings that fit the same swings, so treat it as a reading rather than the reading. It was chosen from 2 labellings that survived the rules, counting shorter readings of the same bars.
On past moves of this shape the leg has usually ended somewhere between $179.25 and $189.41 — that is where it has tended to end if the count holds, not a forecast of where the price goes.
Alternate reading: The same swings also read as a completed three-part correction, which fails on a close above $198.49.
This labelling was already in place when we began recording count changes on 2026-08-13, so how long it has stood is not something we can say yet.
Read from daily closes as of 2026-08-21.
An Elliott-wave count describes the swings already printed and the level that would disprove it. It is not a forecast, a target, or advice.
Screens: Trading above the 200-day moving average · Recent golden cross (50-day crossed above 200-day) · Tested and reclaimed 200-day support · in a strong, established uptrend (ADX) · At the top of its 14-day range (stochastic above 80) · Near the golden pocket (has given back about two thirds of its 52-week move) | Learn: moving average · golden cross · adx · rsi · macd · breakout
Based on daily closing prices as of 2026-08-21. Describes past price behavior only — informational, not financial advice.
Analyst consensus
- Consensus ratingHold (2.52 mean, 1=Strong Buy…5=Strong Sell) — 21 analysts
- Mean price target$206.48 range $182.00 – $238.00; median $201.00
Analyst estimates, as of 2026-08-22. These are third-party analyst opinions and price targets, aggregated — not a recommendation, prediction, or advice from stocks-llm. Informational only.
Analyst EPS estimate for MRSH
- Consensus EPS estimate$1.98 next reporting period, as of 2026-08-22
Change over time is not available yet: it needs two readings of the same reporting period at least 30 days apart, and we have been recording these estimates since 2026-08-04. An estimate for a DIFFERENT quarter is not a revision, so a reading from before the last report is never compared with one after it.
The consensus estimate for the next reporting period, and how it has moved between readings of that SAME period. A change is measured only between readings estimating one period — when a company reports, the consensus moves to the next quarter and the two numbers are not comparable. Informational only, not a forecast and not advice.
Key risks (from latest filing)
["Exposure to interest rate fluctuations and investment performance volatility, which affects pension-related assets and liabilities and client valuations","Foreign currency translation impacts, as evidenced by significant foreign exchange adjustments in comprehensive income statements","Dependence on high-margin commission and fee revenue, making the business sensitive to market downturns and insurance placement activity"]
What changed in the latest 10-Q
AI-assisted comparison of MRSH's 10-Q filed 2026-04-16 against the prior one filed 2025-10-16.
Management's Discussion & Analysis (MD&A)
- Added:
- Newer filing (2026-04-16) specifies quarter ended March 31, 2026 (whereas older filing was for quarter ended September 30, 2024)
- Newer filing adds: 'In the first quarter of 2026, the Company recorded an estimated liability and legal expenses of $425 million related to the Greensill litigation'
- Newer filing adds: 'In March 2026, the Company repaid $600 million of 3.750% senior notes at maturity'
- Newer filing adds: 'In February 2026, the Company issued $600 million of 4.950% senior notes due 2036'
- Newer filing adds reference to 'Marsh Risk's revenue' as distinct line item for three months ended March 31, 2026 ($3.7 billion)
- Newer filing adds 'Marsh Management Consulting's revenue' for three months ended March 31, 2026 ($897 million)
- Removed:
- Older filing (2025-10-16) included nine-month period results; newer filing omits nine-month comparisons
- Older filing mentioned 'Thrive' three-year program launched in third quarter 2025; newer filing does not reference this program
- Older filing referenced 'Oliver Wyman Group' as a reporting segment; newer filing does not mention Oliver Wyman Group
- Older filing stated 'multiple major wars and global conflicts'; newer filing revised to 'conflict in the Middle East and other wars and global conflicts'
- Reworded:
- Macroeconomic risk language changed from 'multiple major wars and global conflicts' (older) to 'the conflict in the Middle East and other wars and global conflicts' (newer)
- Older filing reported 'Marsh's revenue' with specific dollar amounts; newer filing reports 'Marsh Risk's revenue' as the comparable metric
- Older filing included 'Oliver Wyman Group's revenue' metrics; newer filing replaced with 'Marsh Management Consulting's revenue' metrics
- Notes:
- The two filings cover different fiscal quarters (Q3 2025 vs Q1 2026), making direct operational comparisons difficult
- Older filing included nine-month year-to-date data which newer filing does not present, limiting comparability
- The change from 'Oliver Wyman Group' to 'Marsh Management Consulting' may reflect organizational restructuring, but the documents do not explicitly explain this change
Risk Factors
The two filings could not be meaningfully compared for this section.
AI-assisted comparison of two SEC filing sections. It describes wording and theme changes only, makes no materiality, legal, or investment judgement, and is not financial advice. Informational only — not financial advice.
Insider activity (SEC Form 4)
0 open-market purchases and 5 open-market sales by insiders in the last 90 days.
- Last 30 days0 buys · 3 sells ($3M) — 3 selling insiders
- Last 90 days0 buys · 5 sells ($8M) — 5 selling insiders
- Last 180 days0 buys · 5 sells ($8M) — 5 selling insiders
Activity heuristic: net selling (a transparent product heuristic from the counts above, not a prediction or advice)
Most recent open-market transaction: 2026-08-06. As of 2026-08-24.
View full insider trading history → View SEC Form 3/4/5 filingsAsk about MRSH's insider activity →
Only open-market purchases (SEC code P) and sales (code S) are counted here. Option exercises, vesting/awards, gifts, and shares withheld for taxes are excluded — they are compensation or mechanical, not open-market conviction. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan) and are not necessarily bearish; open-market buying is not a recommendation to buy. Informational only — not financial advice.
Institutional ownership (13F)
5 institutional 13F filers reported holding MRSH as of 2026-03-31 (quarter-end position, filed within 45 days).
- Distinct 13F filers 5
- Reported shares held 74,934,113
- Reported value $12,997,322,147
reported quarterly holdings change (2025-12-31 → 2026-03-31): 0 new, 2 increased, 3 decreased, 1 exited. Change counts cover only managers that filed 13F reports in BOTH quarters, derived between two quarter-end snapshots — not same-day trades; a single manager is never said to have "bought" or "sold".
Institutional holdings are quarter-end long positions reported on SEC Form 13F-HR, filed up to 45 days after the quarter ends — they are delayed, are not real-time trades, exclude short positions and most non-US securities, and are not investment advice. Any increase/decrease is a reported change between two quarterly snapshots, not a same-day purchase or sale. These are quarter-end snapshots from the 13F filings on SEC EDGAR, filed within 45 days — not real-time, and any change is a difference between two quarterly reports, not a same-day trade. Informational only — not financial advice.
Short interest (FINRA)
MRSH had 7,498,602 shares of reported short interest as of the 2026-07-31 FINRA settlement date (delayed, bi-monthly; not real-time).
MRSH had 1.57% of its shares outstanding sold short as of the 2026-07-31 FINRA settlement date (percent of FLOAT would be higher — float is not disclosed in the source). FINRA reported 2.41 days to cover at the same settlement.
- Reported short interest (shares) 7,498,602
- Short interest (% of shares outstanding) 1.57%
- Prior settlement (shares) 6,737,059
- Reported change 11.3%
- Days to cover (reported) 2.41
Reported to FINRA as of the 2026-07-31 settlement date. Short interest is reported to FINRA and published on a delayed, bi-monthly schedule (as of a settlement date, disseminated roughly eight business days later) — it is NOT real-time, does not cover every venue or all US trading, and is not a short-squeeze prediction or investment advice. Days-to-cover is the value FINRA reports; percent of float is not shown because the source file carries no share-count denominator — where a percent appears it is of shares OUTSTANDING, the larger base, and is therefore a floor on percent of float. Informational only — not financial advice.
Competitors & peers
- Aon (AON)
- Willis Towers Watson (WTW)
- Arthur J. Gallagher & Co. (AJG)
- Brown & Brown (BRO)
- Mercer (internal brand)
- Oliver Wyman (internal brand)
AI-enriched competitor set. Linked names are companies covered by stocks-llm; other named peers are shown for reference only.
Compare MRSH vs…
Marsh McLennan is found in…
Frequently asked questions
What does Marsh McLennan (MRSH) do?
Marsh & McLennan is a global professional services company that provides consulting, insurance brokerage, and risk management solutions. The company operates through two main segments: Marsh & McLennan Agency (MMA), which offers insurance brokerage, employee benefits consulting, and risk services; and Mercer, which provides human capital and investment consulting services.
What sector is Marsh McLennan (MRSH) in?
Marsh McLennan (MRSH) is classified in the Financials sector. Its industry is Insurance brokers and professional services. It trades on NYSE.
Does MRSH pay a dividend?
Yes — Marsh McLennan (MRSH) pays a dividend, with an indicated yield of about 1.98% and at least 4 years of non-decreasing per-share dividends (SEC EDGAR XBRL) — we do not hold the year before it, so the real streak may be longer (market data, as of 2026-08-24). Informational only — not financial advice.
Who are Marsh McLennan's (MRSH) competitors?
Notable peers of Marsh McLennan (MRSH) include Aon, Willis Towers Watson, Arthur J. Gallagher & Co., Brown & Brown and Mercer (internal brand). This peer set is informational only — not financial advice.
Is Marsh McLennan (MRSH) overbought or oversold right now?
Marsh McLennan (MRSH) is currently neither overbought nor oversold — its 14-day RSI (a 0–100 momentum gauge) is 60, in the neutral middle (as of 2026-08-21). RSI describes recent price momentum, not a forecast — informational only, not financial advice.
Where does stocks-llm's data on MRSH come from?
Fundamentals and prices come from market data, as of 2026-08-24; company filings and profile facts come from SEC EDGAR. All figures are delayed daily-close data shown with their as-of date — informational only, not financial advice.
Fundamentals: market data, as of 2026-08-24. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-08-21.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date.